SCHEMBL8286372

SCHEMBL8286372

CCOC(=O)c1cc(C)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.47
KDM4E B2RXH2 5/20 0.46
HTT P42858 2/20 0.46
PDE11A Q9HCR9 1/20 0.43
HPGD P15428 4/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 3/20 0.41
GAA P10253 1/20 0.41
GABRA2 P47869 3/20 0.41
GABRB2 P47870 3/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MAT2A P31153 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286390 0.92 PDE11A (0.40) CSF1RKDM4EHTTPDE11AHPGD
SCHEMBL8287518 0.88 PDE11A (0.44) CSF1RKDM4EHTTPDE11AHPGD
SCHEMBL5872175 0.87 PDE11A (0.47) CSF1RKDM4EHTTPDE11AHPGD
SCHEMBL8286396 0.87 PDE11A (0.44) CSF1RKDM4EHTTPDE11AHPGD
SCHEMBL5871541 0.86 PDE11A (0.46) CSF1RKDM4EHTTPDE11AHPGD
SCHEMBL8285174 0.86 PDE11A (0.43) CSF1RKDM4EHTTPDE11AHPGD
SCHEMBL8287397 0.85 PDE11A (0.46) CSF1RKDM4EHTTPDE11AHPGD
SCHEMBL8287393 0.85 PDE11A (0.46) KDM4EHTTPDE11AHPGDALDH1A1
SCHEMBL8286384 0.85 PDE11A (0.42) CSF1RKDM4EHTTPDE11AHPGD
SCHEMBL8285169 0.85 PDE11A (0.45) CSF1RKDM4EHTTPDE11AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed